<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Joe Wallace - Computational Chemistry & Data Science</title>

  <!-- Link to external stylesheet -->
  <link rel="stylesheet" href="assets/css/style.css"/>

  <!-- Internal styles specific to this page (can be moved to style.css if preferred) -->
  <style>
    /* Basic Reset & Layout */
    body {
      display: flex;
      flex-direction: column;
      min-height: 100vh;
      margin: 0;
      font-family: Arial, sans-serif;
      background-color: #fafafa;
      color: #333;
    }
    header {
      background-color: #333;
      color: #fff;
      padding: 1em 0;  
    }
    .header-container {
      width: 90%;
      max-width: 1200px;
      margin: 0 auto;
      display: flex;
      flex-wrap: wrap;
      align-items: center;
      justify-content: space-between;
    }
    /* Logo / Name */
    .header-container h1 {
      margin: 0;
    }
    .header-container h2 {
      margin: 0;
      font-weight: 400;
      font-size: 1.2rem;
    }

    /* Navigation */
    nav ul {
      list-style: none;
      display: flex;
      gap: 1em;
      margin: 0;
      padding: 0;
    }
    nav ul li {
      margin: 0;
    }
    nav ul li a {
      text-decoration: none;
      color: #fff;
      padding: 0.5em;
      border-radius: 4px;
      transition: background-color 0.3s;
    }
    nav ul li a:hover,
    nav ul li a.active {
      background-color: #444;
    }

    /* Main content area */
    main {
      flex: 1;
      width: 90%;
      max-width: 1200px;
      padding-top: 6em;  
      margin: 0 auto;    
    }

    /* Content sections */
    .content-section {
      margin-top: 2em;
      background-color: #fff;
      padding: 2em;
      border-radius: 8px;
      box-shadow: 0 2px 5px rgba(0,0,0,0.1);
    }
    .content-section h2 {
      margin-bottom: 1em;
      color: #333;
    }
    .content-section p,
    .content-section li {
      color: #555;
      line-height: 1.6;
    }

    /* Footer */
    footer {
      text-align: center;
      padding: 1em 0;
      background-color: #f1f1f1;
    }
    footer p {
      margin: 0;
      color: #666;
    }
  </style>
</head>

<body>
  <!-- ========== HEADER ========== -->
  <header>
    <div class="header-container">
      <div>
        <h1>Joe Wallace</h1>
        <h2>Computational Chemistry &amp; Data Science</h2>
      </div>
      <nav>
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="about.html">About</a></li>
          <li><a href="cv.html">CV</a></li>
          <li><a href="research.html" class="active">Research</a></li>
          <li><a href="blog/index.html">Blog</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <!-- ========== MAIN CONTENT ========== -->
  <main>
  <!-- ===== Academic Research ===== -->
  <section class="content-section">
    <h2>Academic Research</h2>
    <p>
      My formal research background spans advanced computational methods
      and experimental validation in nanoparticle systems, bridging data
      science with molecular modeling to drive innovation in pharmaceutical
      and biotech applications.
    </p>
    <ul>
      <li>
        <hr>
        <strong>Post-Doctoral Research (De Vivo Lab, IIT Genova / Mancin Lab, Padova)</strong>
        <p>
          My post-doctoral work centered on computational strategies for
          nanoparticle functionalization in sensing applications. I employed
          molecular dynamics (MD) simulations, enhanced sampling (umbrella
          sampling, steered MD), and machine learning (ridge regression, SVM,
          random forest) to predict and optimize nanoparticle-ligand
          interactions. This synergy of molecular modeling and data-driven
          approaches provided robust insights into nanoparticle behavior,
          paving the way for innovative applications in pharma, biotech, and
          environmental cleanup (nanoplastics).
        </p>
        <strong>Key Skills:</strong> MD simulations, enhanced sampling (umbrella &amp; steered MD), 
        machine learning (ridge regression, SVM, random forest), Python, data analysis, 
        structural characterization, HPC workflows.
      </li>
      <hr>

      <li>
        <strong>PhD Research (University of Liverpool, A*STAR Singapore, &amp; Paris Sorbonne Nord)</strong>
        <p>
          During my PhD, I investigated peptide-capped gold nanoparticles through
          an interdisciplinary mix of experimental and computational methods.
          Techniques such as FTIR, UV/Vis, circular dichroism, and protein
          expression were combined with MD simulations in GROMACS, Python-based
          modeling, and advanced sampling (umbrella sampling, REMD,
          metadynamics). This work refined my expertise in structural
          characterization, molecular modeling, and data science—expertise I’m
          now applying to drug discovery and cheminformatics projects in the
          biotech sector.
        </p>
        <strong>Key Skills:</strong> Experimental characterization (FTIR, UV/Vis, CD, crystallography), 
        protein expression, GROMACS, Python scripting, enhanced sampling (umbrella, REMD, 
        metadynamics), data science workflows.
      </li>
      <hr>
    </ul>
  </section>


    <!-- ===== Personal (Side) Projects ===== -->
    <section class="content-section">
      <h2>Personal AI-Driven Projects</h2>
      <p>
        In parallel to my formal research, I’ve been exploring various AI/ML 
        applications in computational chemistry, drug discovery, and
        biologics design. These projects are personal initiatives, aimed
        at expanding my skill set and staying at the forefront of
        data-driven methodologies in the biotech space.
      </p>
    </section>

    <!-- ===== Project 1: AI for Small Molecule Drug Discovery ===== -->
    <section class="content-section">
      <h2>AI for Small Molecule Drug Discovery</h2>
      <p>
        In this personal project, I explore how AI, especially Graph Neural
        Networks (GNNs), can predict drug-protein binding affinities
        for small molecules. My workflow involves:
      </p>
      <ul>
        <li>Preprocessing molecular data with <em>RDKit</em> &amp; <em>DeepChem</em></li>
        <li>Running docking simulations (<em>AutoDock Vina</em>) &amp; 
            MD for validation
        </li>
        <li>Training GNN models to predict binding affinity &amp; ADMET profiles</li>
        <li>Iterative refinement &amp; lead optimization</li>
      </ul>
      <p>
        Check my <a href="blog/index.html">blog</a> for tutorials on how to set
        up a small molecule AI pipeline, or see my <a href="cv.html">CV</a> for
        publications &amp; code repositories (where available).
      </p>
    </section>

    <!-- ===== Project 2: AI for Peptide & Biologics Design ===== -->
    <section class="content-section">
      <h2>AI for Peptide &amp; Biologics Design</h2>
      <p>
        Working with peptides and biologics provides new avenues for
        therapeutic innovation. My main goals include:
      </p>
      <ul>
        <li>Using <strong>ProteinMPNN</strong> &amp; <strong>AlphaFold</strong> 
            to generate novel peptide therapeutics
        </li>
        <li>Running molecular dynamics on candidate designs for
            stability &amp; efficacy
        </li>
        <li>Leveraging <strong>DiffDock</strong> for protein-ligand &amp; 
            peptide docking
        </li>
      </ul>
      <p>
        The synergy of AI-driven design and structural biology has
        the potential to radically shorten discovery timelines
        for modern biotherapeutics.
      </p>
    </section>

    <!-- ===== Project 3: Multi-Omics for Drug Target Discovery ===== -->
    <section class="content-section">
      <h2>Multi-Omics for Drug Target Discovery</h2>
      <p>
        Biological data—from genomics, proteomics, transcriptomics, and more—can
        reveal new therapeutic targets. In this project, I'm leveraging:
      </p>
      <ul>
        <li><strong>Scanpy</strong> and Python data science libraries 
            for single-cell analyses
        </li>
        <li>Machine learning (random forests, neural networks) 
            to classify disease states
        </li>
        <li>Integrating molecular modeling insights to identify druggable targets</li>
      </ul>
      <p>
        By bridging multi-omics data with structural insights, I hope
        to pinpoint high-potential targets earlier in the pipeline.
      </p>
    </section>

    <!-- ===== Project 4: Generative AI for De Novo Drug Design ===== -->
    <section class="content-section">
      <h2>Generative AI for De Novo Drug Design</h2>
      <p>
        I’m also exploring generative models (e.g., <strong>MolGAN</strong>,
        <strong>ChemGPT</strong>) to create novel molecular structures with
        optimized drug-like properties. Key areas include:
      </p>
      <ul>
        <li>Reinforcement learning for property optimization</li>
        <li>Assessing synthetic feasibility &amp; ADME/Tox predictions</li>
        <li>Combining generative models with docking &amp; 
            molecular dynamics feedback loops
        </li>
      </ul>
      <p>
        This approach aims to automate hypothesis generation and drastically
        speed up the discovery cycle.
      </p>
    </section>
  </main>

  <!-- ========== FOOTER ========== -->
  <footer>
    <p>&copy; 2025 Joe Wallace. All Rights Reserved.</p>
  </footer>
</body>
</html>
